Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Shares of Cardinal Health Inc. CAH inched 0.93% higher to $122.53 Wednesday, on what proved to be an all-around favorable ...

This is the fourth industrial property the buyer has acquired in Grove City over the last two weeks. A Cardinal Health ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

Cardinal Health (CAH – Research Report) received a Buy rating and a $144.00 price target from TD Cowen analyst Charles Rhyee today. The ...

TD Cowen upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $144, up from $130. The firm believes new customers, strong ...

Here are five recent updates on the five biggest GI chains, as reported by Becker's: Dallas-based GI Alliance entered a definitive agreement with Dublin, Ohio-based pharmaceutical distributor and ...

Evercore ISI has upgraded Cardinal Health (NYSE:CAH) to outperform from in line, citing the company's improved outlook. The ...

The clinic was part of a nationwide movement of doctors and other medical workers calling in sick to protest war in the ...

This is independent of pre-existing ... Young English Speakers Are Most Comfortable With Digital Health Dec. 17, 2024 — Digital health tools, such as patient portals, treatment apps and online ...

Saeed Sadeghi, MD, discusses valuable feedback he heard from oncologists on the use of luspatercept-aamt in patients with low-risk myelodysplastic syndrome.